Cargando…

Exploration of the methods of establishing the minimum clinical important difference based on anchors and their applications in the quality of life measurement scale QLICP-BR (V2.0) for breast cancer

OBJECTIVE: The measurement of the quality of life (QOL) in patients with breast cancer can evaluate the therapeutic effects of medical treatments and help to provide reference for clinical decisions. The minimum clinically important difference (MCID) can be better used in clinical interpretation tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xuan, Liu, Yuxi, Tan, Jianfeng, Hu, Liren, Chen, Huanwei, Wan, Chonghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083364/
https://www.ncbi.nlm.nih.gov/pubmed/37051543
http://dx.doi.org/10.3389/fonc.2023.1123258
_version_ 1785021494064054272
author Zhou, Xuan
Liu, Yuxi
Tan, Jianfeng
Hu, Liren
Chen, Huanwei
Wan, Chonghua
author_facet Zhou, Xuan
Liu, Yuxi
Tan, Jianfeng
Hu, Liren
Chen, Huanwei
Wan, Chonghua
author_sort Zhou, Xuan
collection PubMed
description OBJECTIVE: The measurement of the quality of life (QOL) in patients with breast cancer can evaluate the therapeutic effects of medical treatments and help to provide reference for clinical decisions. The minimum clinically important difference (MCID) can be better used in clinical interpretation than the traditional statistical significance. Based on the anchors, a variety of ways including traditional and updated anchor-based methods were used to explore most suitable MCID, so that to find better interpretation on scores of the scale QLICP-BR(V2.0) (Quality of Life Instruments for Cancer Patients-Breast cancer). METHODS: According to the investigation data of breast cancer patients before and after treatment, the most relevant indicators in various domains of QLICP-BR (V2.0) was found as an anchor to statistically analyze the value of MCID, and three analysis methods of anchors were used: Traditional anchor-based method, ROC curve method, multiple linear regression model analysis. Anchors are divided into four standards according to the degree of change in the treatment effect: one grade difference (Standard A), at least one grade difference (Standard B), one grade better (Standard C), better (Standard D). The final MCID value is selected from different statistical methods and classification standards that are most suitable for clinicians to use. RESULTS: Using Q29 of the EORTC QLQ-C30 as an anchor has the highest correlation with each domain of QLICP. The order of magnitude of MCID values among the four standard groups is: standard A< Standard C< Standard B< Standard D. The MCID value obtained by the ROC curve method is the most stable and is least affected by the sample size, and the MCID value obtained by the multiple linear regression model is the least. After comparisons and discussions, Standard C in the multiple linear regression model is used to determine the final MCID, which is the closest to other methods. After integer the MCID values of Physical domain (PHD), Psychological domain (PSD), Social domain (SOD), Common symptoms and side effect domain (SSD), Core/general module (CGD), Specific domain (SPD), Total score(TOT) can be taken as 15,10, 10, 11, 10, 9 and 9, respectively. CONCLUSION: In the evaluation of the QOL of breast cancer patients, although the results of MCID values produced by different methods are different, the results are relatively close. The anchor-based methods make the results of MCID more clinically interpretable by introducing clinical variables, and clinicians and researchers can choose the appropriate method according to the research purpose.
format Online
Article
Text
id pubmed-10083364
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100833642023-04-11 Exploration of the methods of establishing the minimum clinical important difference based on anchors and their applications in the quality of life measurement scale QLICP-BR (V2.0) for breast cancer Zhou, Xuan Liu, Yuxi Tan, Jianfeng Hu, Liren Chen, Huanwei Wan, Chonghua Front Oncol Oncology OBJECTIVE: The measurement of the quality of life (QOL) in patients with breast cancer can evaluate the therapeutic effects of medical treatments and help to provide reference for clinical decisions. The minimum clinically important difference (MCID) can be better used in clinical interpretation than the traditional statistical significance. Based on the anchors, a variety of ways including traditional and updated anchor-based methods were used to explore most suitable MCID, so that to find better interpretation on scores of the scale QLICP-BR(V2.0) (Quality of Life Instruments for Cancer Patients-Breast cancer). METHODS: According to the investigation data of breast cancer patients before and after treatment, the most relevant indicators in various domains of QLICP-BR (V2.0) was found as an anchor to statistically analyze the value of MCID, and three analysis methods of anchors were used: Traditional anchor-based method, ROC curve method, multiple linear regression model analysis. Anchors are divided into four standards according to the degree of change in the treatment effect: one grade difference (Standard A), at least one grade difference (Standard B), one grade better (Standard C), better (Standard D). The final MCID value is selected from different statistical methods and classification standards that are most suitable for clinicians to use. RESULTS: Using Q29 of the EORTC QLQ-C30 as an anchor has the highest correlation with each domain of QLICP. The order of magnitude of MCID values among the four standard groups is: standard A< Standard C< Standard B< Standard D. The MCID value obtained by the ROC curve method is the most stable and is least affected by the sample size, and the MCID value obtained by the multiple linear regression model is the least. After comparisons and discussions, Standard C in the multiple linear regression model is used to determine the final MCID, which is the closest to other methods. After integer the MCID values of Physical domain (PHD), Psychological domain (PSD), Social domain (SOD), Common symptoms and side effect domain (SSD), Core/general module (CGD), Specific domain (SPD), Total score(TOT) can be taken as 15,10, 10, 11, 10, 9 and 9, respectively. CONCLUSION: In the evaluation of the QOL of breast cancer patients, although the results of MCID values produced by different methods are different, the results are relatively close. The anchor-based methods make the results of MCID more clinically interpretable by introducing clinical variables, and clinicians and researchers can choose the appropriate method according to the research purpose. Frontiers Media S.A. 2023-03-27 /pmc/articles/PMC10083364/ /pubmed/37051543 http://dx.doi.org/10.3389/fonc.2023.1123258 Text en Copyright © 2023 Zhou, Liu, Tan, Hu, Chen and Wan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhou, Xuan
Liu, Yuxi
Tan, Jianfeng
Hu, Liren
Chen, Huanwei
Wan, Chonghua
Exploration of the methods of establishing the minimum clinical important difference based on anchors and their applications in the quality of life measurement scale QLICP-BR (V2.0) for breast cancer
title Exploration of the methods of establishing the minimum clinical important difference based on anchors and their applications in the quality of life measurement scale QLICP-BR (V2.0) for breast cancer
title_full Exploration of the methods of establishing the minimum clinical important difference based on anchors and their applications in the quality of life measurement scale QLICP-BR (V2.0) for breast cancer
title_fullStr Exploration of the methods of establishing the minimum clinical important difference based on anchors and their applications in the quality of life measurement scale QLICP-BR (V2.0) for breast cancer
title_full_unstemmed Exploration of the methods of establishing the minimum clinical important difference based on anchors and their applications in the quality of life measurement scale QLICP-BR (V2.0) for breast cancer
title_short Exploration of the methods of establishing the minimum clinical important difference based on anchors and their applications in the quality of life measurement scale QLICP-BR (V2.0) for breast cancer
title_sort exploration of the methods of establishing the minimum clinical important difference based on anchors and their applications in the quality of life measurement scale qlicp-br (v2.0) for breast cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083364/
https://www.ncbi.nlm.nih.gov/pubmed/37051543
http://dx.doi.org/10.3389/fonc.2023.1123258
work_keys_str_mv AT zhouxuan explorationofthemethodsofestablishingtheminimumclinicalimportantdifferencebasedonanchorsandtheirapplicationsinthequalityoflifemeasurementscaleqlicpbrv20forbreastcancer
AT liuyuxi explorationofthemethodsofestablishingtheminimumclinicalimportantdifferencebasedonanchorsandtheirapplicationsinthequalityoflifemeasurementscaleqlicpbrv20forbreastcancer
AT tanjianfeng explorationofthemethodsofestablishingtheminimumclinicalimportantdifferencebasedonanchorsandtheirapplicationsinthequalityoflifemeasurementscaleqlicpbrv20forbreastcancer
AT huliren explorationofthemethodsofestablishingtheminimumclinicalimportantdifferencebasedonanchorsandtheirapplicationsinthequalityoflifemeasurementscaleqlicpbrv20forbreastcancer
AT chenhuanwei explorationofthemethodsofestablishingtheminimumclinicalimportantdifferencebasedonanchorsandtheirapplicationsinthequalityoflifemeasurementscaleqlicpbrv20forbreastcancer
AT wanchonghua explorationofthemethodsofestablishingtheminimumclinicalimportantdifferencebasedonanchorsandtheirapplicationsinthequalityoflifemeasurementscaleqlicpbrv20forbreastcancer